Cas:675149-75-4 4-(chloromethyl)-1,3-oxazole,hydrochloride manufacturer & supplier

We serve Chemical Name:4-(chloromethyl)-1,3-oxazole,hydrochloride CAS:675149-75-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-(chloromethyl)-1,3-oxazole,hydrochloride

Chemical Name:4-(chloromethyl)-1,3-oxazole,hydrochloride
CAS.NO:675149-75-4
Synonyms:4-(chloromethyl)-1,3-oxazole,hydrochloride
Molecular Formula:C4H5Cl2NO
Molecular Weight:153.99500
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:26.03000
Exact Mass:152.97500
LogP:2.21540

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-(chloromethyl)-1,3-oxazole,hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(chloromethyl)-1,3-oxazole,hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(chloromethyl)-1,3-oxazole,hydrochloride Use and application,4-(chloromethyl)-1,3-oxazole,hydrochloride technical grade,usp/ep/jp grade.


Related News: United Airlines — which announced that it will suspend flights to Beijing, Chengdu and Shanghai from February 6 — is also reducing flights from the US to Hong Kong. 4-(chloromethyl)-1,3-oxazole,hydrochloride manufacturer The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. 4-(chloromethyl)-1,3-oxazole,hydrochloride supplier The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. 4-(chloromethyl)-1,3-oxazole,hydrochloride vendor South Korea said on Sunday that it would deny entry to any foreigners who have traveled to Wuhan and surrounding Hubei Province in China in the past 14 days. 4-(chloromethyl)-1,3-oxazole,hydrochloride factory Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.